(19)

(11)

EP 4 739 211 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24745868.0 (22) Date of filing: 05.07.2024

(51) International Patent Classification (IPC):  A61B 5/145(2006.01) G16H 40/63(2018.01) A61B 5/00(2006.01) G16H 50/20(2018.01) (52) Cooperative Patent Classification (CPC): A61B 5/14532; G16H 50/20; G16H 40/63; A61B 2560/0271; A61B 5/7475 (86) International application number: PCT/US2024/036859 (87) International publication number: WO 2025/014790 (16.01.2025 Gazette 2025/03)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 07.07.2023 US 202363525490 P (71) Applicant: Abbott Diabetes Care Inc. Alameda, California 94502 (US)	(72) Inventors: NAGRA, Saranpreet S. Alameda, California 94501 (US) KABEL-ECKES, Sabine Mountain View, California 94043 (US) PARTHASARATHY, Vyshnnavi Fremont, California 94538 (US) LOREY, Daniel J. Emerald Hills, California 94062 (US) (74) Representative: Mathys & Squire  32 London Bridge Street The Shard London SE1 9SG London SE1 9SG (GB)